A lipase fusion feasts on fat

Philip M.M. Ruppert, Sander Kersten*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The enzyme lipoprotein lipase (LPL) is responsible for breaking down triglycerides in the blood. Mutations in LPL cause a rare but debilitating disorder characterized by excessive plasma triglyceride levels for which treatment options are limited. Nimonkar et al. now present a fusion protein between LPL and its physiological transporter GBIHBP1 that is highly active and largely resistant to physiological inhibitors of LPL. Injecting this fusion protein effectively lowers plasma triglycerides in mice and represents a promising new approach for lowering triglycerides in patients with familial chylomicronemia syndrome.

Original languageEnglish
Pages (from-to)2913-2914
Number of pages2
JournalJournal of Biological Chemistry
Volume295
Issue number10
DOIs
Publication statusPublished - 6 Mar 2020

    Fingerprint

Cite this